Cargando…
Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies
Tau aggregation is one of the major features in Alzheimer's disease and in several other tauopathies, including frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), and progressive supranuclear palsy (PSP). More than 35 mutations in the tau gene have been identified from...
Autores principales: | Zhou, Jianhua, Yu, Qingming, Zou, Tie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604894/ https://www.ncbi.nlm.nih.gov/pubmed/19090983 http://dx.doi.org/10.1186/1471-2202-9-S2-S10 |
Ejemplares similares
-
Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008) -
hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3′ Splice Sites
por: Liu, Yongchao, et al.
Publicado: (2020) -
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A
por: Qian, Wei, et al.
Publicado: (2011) -
Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019) -
Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
por: Sud, Reeteka, et al.
Publicado: (2014)